EUVIMEDEUVIMED entdecken
Crossref

Controlled-release hydrogel loaded with engineered extracellular vesicles for treatment of chronic endometritis

Haixia Li, Ruixue Hu, Yue Zhang, Junli Zhang

Journal of Controlled Release · 2026

DOI: 10.1016/j.jconrel.2026.115267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2026. Verfasst von Haixia Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhengzhou University, Henan Key Laboratory of Nanomedicine for Targeting Diagnosis and Treatment, Zhengzhou 450001…. Hauptthemen laut MEDLINE: Endometritis, Anti-Bacterial Agents, Hydrogels, Extracellular Vesicles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Henan Provincial Education Development Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic endometritis (CE) is an important factor contributing to infertility and adverse pregnancy outcomes. Current clinical management mainly relies on antibiotics such as ceftizoxime (CTX), whose efficacy is limited by poor oral bioavailability and short half-life. To address these limitations, this study developed intelligent, responsive hydrogel incorporating Leonurus japonicus Houtt derived extracellular vesicles (EVs) loaded with CTX. The hydrogel forms sustained-release drug reservoir in situ within the uterine cavity, enabling controlled release in response to the local inflammatory microenvironment. EVs can effectively regulate the inflammatory microenvironment by inhibiting activation of NF-κB pathway and NLRP3 inflammasome, downregulating the pro-inflammatory factor TNF-α, and upregulating the anti-inflammatory factors IL-10 and TGF-β1, thereby significantly promoting endometrial repair and reducing fibrotic areas. Meanwhile, CTX provides targeted antibacterial activity to eliminate pathogens and control infection. Through exerting antibacterial, anti-inflammatory, and tissue repairing, the developed intelligent, responsive hydrogel system offers a promising strategy for treatment of CE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometritisAnti-Bacterial AgentsHydrogelsExtracellular VesiclesFemaleAnimalsDelayed-Action PreparationsHumansChronic DiseaseAnti-Inflammatory AgentsEndometrium

Stichwörter der Autor:innen

Chronic endometritisControlled releaseExtracellular vesiclesHydrogelLocal administration

Substanzen

Delayed-Action PreparationsAnti-Bacterial AgentsHydrogelsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Zhengzhou University, Henan Key Laboratory of Nanomedicine for Targeting Diagnosis and Treatment, Zhengzhou 450001, China.
  • School of Pharmaceutical Sciences, Zhengzhou University, Henan Key Laboratory of Nanomedicine for Targeting Diagnosis and Treatment, Zhengzhou 450001, China. Electronic address: zhangjunli0927@zzu.edu.cn.

Förderung

  • Henan Provincial Education Development Foundation

Zitieren

APA

Li, H., Hu, R., Zhang, Y., & Zhang, J. (2026). Controlled-release hydrogel loaded with engineered extracellular vesicles for treatment of chronic endometritis. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2026.115267

Vancouver

Li H, Hu R, Zhang Y, Zhang J. Controlled-release hydrogel loaded with engineered extracellular vesicles for treatment of chronic endometritis. Journal of Controlled Release. 2026. doi:10.1016/j.jconrel.2026.115267

BibTeX
@article{Li2026,
  author = {Li, Haixia and Hu, Ruixue and Zhang, Yue and Zhang, Junli},
  title = {Controlled-release hydrogel loaded with engineered extracellular vesicles for treatment of chronic endometritis},
  journal = {Journal of Controlled Release},
  year = {2026},
  doi = {10.1016/j.jconrel.2026.115267}
}
Kostenlos starten →